CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES

Their core work

CHU Rennes is a major French university hospital combining clinical care, medical research, and teaching. In H2020, they contribute clinical expertise across vaccine monitoring, paediatric oncology, regenerative medicine, and epidemiological surveillance. Beyond traditional healthcare, they serve as a living lab for digital health applications including 5G-enabled e-health services and smart mobility solutions for patients and citizens. Their role is typically that of a clinical partner providing real-world hospital environments, patient cohorts, and medical validation for European research consortia.

What they specialise in

How they've shifted over time

CHU Rennes' early H2020 involvement (2015–2018) was rooted in classic clinical research — cardiovascular simulation, vaccine monitoring, paediatric oncology, and neonatal health. From 2019 onward, their portfolio shifted notably toward digital and transport applications: 5G-enabled e-health services, autonomous mobility, and pandemic response networks. This evolution suggests the hospital is actively positioning itself as a testbed where advanced digital technologies meet real clinical environments.

CHU Rennes is moving from pure clinical research toward becoming a hospital-as-a-platform for testing 5G, autonomous transport, and digital health innovations in real patient settings.

How they like to work

CHU Rennes has never coordinated an H2020 project — they consistently join as a clinical partner or third party within large consortia. With 235 unique partners across 26 countries in just 8 projects, they operate in very large networks (averaging ~30 partners per consortium). This profile indicates a hospital that is sought after for its clinical validation capabilities and patient access rather than for driving project strategy.

Despite only 8 projects, CHU Rennes has built connections with 235 unique partners across 26 countries, reflecting participation in large pan-European consortia. Their network spans Western Europe broadly, with no obvious geographic concentration beyond France.

What sets them apart

CHU Rennes stands out as a university hospital that bridges traditional clinical research with emerging digital infrastructure. While many hospitals participate in clinical trials, few also serve as real-world testbeds for 5G networks, autonomous transport, and smart city applications. For consortium builders, this dual profile — deep clinical credibility plus willingness to host technology pilots in a hospital setting — makes them a distinctive partner.

Highlights from their portfolio

• ChiLTERN
  Their largest funded project (EUR 472,356), building a European research network for children's liver tumours — a rare disease area with limited specialist centres.
• 5G-TOURS
  An unusual pivot for a hospital: testing 5G network slicing for e-health, tourism, and media — positioning CHU Rennes as a living lab for next-generation connectivity in healthcare.
• I-MOVE-COVID-19
  Rapid-response pandemic surveillance network demonstrating CHU Rennes' capacity to mobilize for epidemiological emergencies across European hospital networks.